Curanex Pharmaceuticals Inc

Healthcare · Biotechnology · United States

Last price 4.75 USD (At close: Aug 25, 2026) · Market cap 7.45M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New ...